U.S. signs agreement with AstraZeneca to develop COVID-19 antibody treatment
The agency will provide nearly $486 million to AstraZeneca for two Phase 3 clinical trials
source
https://www.thehindu.com/sci-tech/health/us-signs-agreement-with-astrazeneca-to-develop-covid-19-antibody-treatment/article32818236.ece
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment